Leflunomide-induced toxic epidermal necrolysis [2]

International Journal of Dermatology

Volumn 45, Issue 11, 2006, Pages 1370-1371

  Teraki, Yuichi ^a   Hitomi, Katsuhiro ^a   Sato, Yoshihiro ^a   Hamamatsu, Yasushi ^a   Izaki, Seiichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; COLESTYRAMINE; LACTATE DEHYDROGENASE; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE;

ADULT; ALOPECIA; BLISTER; CASE REPORT; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG FEVER; DRUG WITHDRAWAL; EROSION; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; KERATINOCYTE; LETTER; MAINTENANCE DRUG DOSE; RHEUMATOID ARTHRITIS; SKIN BIOPSY; TOXIC EPIDERMAL NECROLYSIS;

ADJUVANTS, IMMUNOLOGIC; ARTHRITIS, RHEUMATOID; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; ISOXAZOLES; MIDDLE AGED;

EID: 33750607894     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.03003.x     Document Type: Letter

References (10)

1. Olsen NJ, Stein CM. New drugs for rheumatoid arthritis. N Engl J Med 2004; 350: 2167-2179.
2. Strand V, Cohen S, Schiff M, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 1999; 159: 2542-2550.
3. Holm EA, Balslev E, Jemec GB. Vasculitis occurring during leflunomide therapy. Dermatology 2001; 203: 258-259.
4. Canonne-Courivaud D, Carpentier O, Dejobert Y, et al. Lichenoid drug reaction to leflunomide. Ann Dermatol Venereol 2003; 130: 435-437.
5. Bandyopadhyay D. Exfoliative dermatitis induced by leflunomide therapy. J Dermatol 2003; 30: 845-846.
6. Mohty R, Chaby G, Pannier M, et al. Drug hypersensitivity syndrome induced by leflunomide. Ann Dermatol Venereol 2003; 130: 551-552.
7. Kerr OA, Murray CS, Tidman MJ. Subacute cutaneous lupus erythematosus associated with leflunomide. Clin Exp Dermatol 2004; 29: 319-320.
8. Fischer TW, Bauer HI, Graefe T, et al. Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide. Dermatology 2003; 207: 386-389.
9. Aventis Pharmaceuticals Inc. Arava Prescribing Information as of March 2005: Aventis Pharmaceuticals Inc., Kansas City, MO.
10. Thami GP, Garg G. Leflunomide in psoriasis and psoriatic arthritis: A preliminary study. Arch Dermatol 2004; 140: 1288-1289.